Cibus Appoints Co-Founder Rory Riggs as Chief Executive Officer
abstract: Announcement of Rory Riggs's appointment as CEO of Cibus, naming him a pioneer in Systems Economics.
author: Rory Riggs
date published: 2021-10-07T00:00:00+00:00
description: Announcement of Rory Riggs's appointment as CEO of Cibus, naming him a pioneer in Systems Economics.
is part of: Rory Riggs
type: Article
type: NewsArticle

Cibus Closes Calyxt Deal
abstract: Coverage of the Cibus/Calyxt merger closing, including a Riggs quote on the combined company's patent portfolio.
author: Rory Riggs
date published: 2023-06-12T00:00:00+00:00
description: Coverage of the Cibus/Calyxt merger closing, including a Riggs quote on the combined company's patent portfolio.
is part of: Rory Riggs
type: Article
type: NewsArticle

Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
abstract: Cibus named #2 Most Innovative Company in agriculture for 2024, with a quote from Riggs.
author: Rory Riggs
date published: 2024-03-19T00:00:00+00:00
description: Cibus named #2 Most Innovative Company in agriculture for 2024, with a quote from Riggs.
is part of: Rory Riggs
type: Article
type: NewsArticle

Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer
abstract: Announcement of Riggs's transition from CEO to Chairman of the Board at Cibus as Craig Wichner becomes CEO.
author: Rory Riggs
date published: 2026-06-08T00:00:00+00:00
description: Announcement of Riggs's transition from CEO to Chairman of the Board at Cibus as Craig Wichner becomes CEO.
is part of: Rory Riggs
type: Article
type: NewsArticle

Cibus Opens Gene Editing Facility for Trait Production
abstract: Coverage of the Cibus Oberlin facility opening, including Riggs's quote on applying pharmaceutical quality standards to plant biology.
author: Rory Riggs
date published: 2023-08-02T00:00:00+00:00
description: Coverage of the Cibus Oberlin facility opening, including Riggs's quote on applying pharmaceutical quality standards to plant biology.
is part of: Rory Riggs
type: Article
type: NewsArticle

Gene Editing to Lead a New Agricultural Revolution
abstract: Authored article by Rory Riggs on precision gene editing and its application to agricultural trait development.
author: Rory Riggs
date published: 2021-11-29T00:00:00+00:00
description: Authored article by Rory Riggs on precision gene editing and its application to agricultural trait development.
is part of: Rory Riggs
publisher: org-future-farming
type: Article

Margaret Crotty and Rory Riggs Health Care Leadership Award, 2024
type: NewsArticle

Proposed Merger Shows That When it Comes to Gene Editing, You Ain’t Seen Nothing Yet
author: Rory Riggs
date published: 2023-03-09T00:00:00+00:00
is part of: Rory Riggs
publisher: org-seedworld
type: Article

Regarding Cloe
type: NewsArticle

Royalty Pharma Co-Founder Writes Open Letter to Board of Elan Ahead of EGM
abstract: Coverage of an open letter authored by Riggs as Royalty Pharma Chairman to the Elan board.
author: Rory Riggs
date published: 2013-06-17T00:00:00+00:00
description: Coverage of an open letter authored by Riggs as Royalty Pharma Chairman to the Elan board.
is part of: Rory Riggs
type: Article
type: NewsArticle

Syntax LLC Announces Launch of Stratified LargeCap ESG Index
abstract: Launch announcement with a direct quote from Riggs on ESG analytics.
author: Rory Riggs
date published: 2020-08-01T00:00:00+00:00
description: Launch announcement with a direct quote from Riggs on ESG analytics.
is part of: Rory Riggs
type: Article
type: NewsArticle

Commentary: Systems Economics — A New Prescription for Risk Management
abstract: Op-ed authored by Rory Riggs articulating the case for functional, systems-based classification of economic data as an alternative to conventional sector-based risk models.
author: Rory Riggs
date published: 2019-07-15T00:00:00+00:00
description: Op-ed authored by Rory Riggs articulating the case for functional, systems-based classification of economic data as an alternative to conventional sector-based risk models.
is part of: Rory Riggs
name: Systems Economics: A New Prescription for Risk Management
publisher: org-pensions-investments
type: Article

BA
credential category: degree
recognized by: Middlebury College
type: EducationalOccupationalCredential

MBA
credential category: degree
recognized by: Columbia University
type: EducationalOccupationalCredential

Functional classification systems
description: Inventor of the coordinate-based Locus Model and Functional Information System for classifying economic activity by function rather than conventional industry category.
term code: thought leader
type: DefinedTerm

Index construction and portfolio classification
description: Built the Syntax Stratified Indices, benchmark indices constructed on functional rather than conventional sector classification.
term code: expert
type: DefinedTerm

Mergers and acquisitions
description: Managing Director in M&A at PaineWebber, 1981–1990.
term code: advanced
type: DefinedTerm

Pharmaceutical royalty finance
description: Founded and built Royalty Pharma into the world's largest acquirer of pharmaceutical royalties, helping create the category as an investable asset class.
term code: expert
type: DefinedTerm

Precision gene editing / agricultural biotechnology
description: Led Cibus's application of production-system methodology to plant biology through the Rapid Trait Development System.
term code: expert
type: DefinedTerm

Columbia University
type: CollegeOrUniversity

Middlebury College
type: CollegeOrUniversity

Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics.
about: Rory Riggs
caption: Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics.
copyright year: 2026
encoding format: image/webp
height: 1024
thumbnail: image-e1813854-thumbnail
width: 1024
type: ImageObject

Managing Member
description: Managing Member of Balfour Venture Partners.
type: Occupation

President, CFO, and Director
description: President, CFO, and Director of BioMatrix, overseeing the launch of Synvisc, a viscosupplementation treatment.
type: Occupation

occupation-biomatrix-inc-president-cfo-and-director-role
end date: 2000
has occupation: President, CFO, and Director
role name: President, CFO, and Director at BioMatrix Inc.
start date: 1996
type: Role

Chairman of the Board
description: Transitioned from Chief Executive Officer to Chairman of the Board in June 2026 as Craig Wichner became CEO.
type: Occupation

occupation-cibus-inc-chairman-of-the-board-role
has occupation: Chairman of the Board
role name: Chairman of the Board at Cibus Inc.
start date: 2026-06
type: Role

Chief Executive Officer
description: Co-founder and CEO of Cibus, the leading precision gene-editing company for agriculture. Applied the Locus Model's functional-systems approach to plant biology through the Rapid Trait Development System (RTDS).
type: Occupation

occupation-cibus-inc-chief-executive-officer-role
end date: 2026-06
has occupation: Chief Executive Officer
role name: Chief Executive Officer at Cibus Inc.
start date: 2021-10-07
type: Role

Chair
description: Chair of eReceivables, a healthcare service technology company.
type: Occupation

Chairman
description: Chairman of Nucelis Inc.
type: Occupation

Managing Director, Mergers & Acquisitions
description: Managing Director in the mergers and acquisitions group at PaineWebber.
type: Occupation

occupation-painewebber-inc-managing-director-mergers-acquisitions-role
end date: 1990
has occupation: Managing Director, Mergers & Acquisitions
role name: Managing Director, Mergers & Acquisitions at PaineWebber Inc.
start date: 1981
type: Role

Chief Executive Officer
description: CEO of RF&P, a real estate investment company owned by the Virginia State Retirement System.
occupation location: Virginia, United States
type: Occupation

Virginia, United States
type: Place

occupation-rfp-corporation-chief-executive-officer-role
end date: 1995
has occupation: Chief Executive Officer
role name: Chief Executive Officer at RF&P Corporation
start date: 1991
type: Role

Chairman and Founder
description: Co-founded Royalty Pharma in 1996 with a $60 million start; built it into the world's largest acquirer of pharmaceutical royalties, holding partial royalty rights on seven of the top thirty drugs sold in the United States. Served as Chairman from 2003 and resigned as a director on June 6, 2024.
type: Occupation

occupation-royalty-pharma-plc-chairman-and-founder-role
end date: 2024-06-06
has occupation: Chairman and Founder
role name: Chairman and Founder at Royalty Pharma plc
start date: 1996
type: Role

General Partner / Co-Founder
description: General Partner and co-founder of Scientia Ventures.
type: Occupation

Executive Chairman / Founder
description: Founded Locus Analytics in 2009 as an economic research firm to pioneer Systems Economics and develop and patent the Functional Information System. Syntax and Locus Analytics merged in March 2023. Built the coordinate-based Locus Model and FIS information infrastructure for finance and economic data, and the Syntax Stratified Indices.
type: Occupation

occupation-syntax-data-syntax-llc-locus-analytics-executive-chai-7ec1f0-role
has occupation: Executive Chairman / Founder
role name: Executive Chairman / Founder at Syntax Data (Syntax LLC / Locus Analytics)
start date: 2009
type: Role

CEO and Trustee
description: CEO and Trustee of the Syntax-affiliated ETF trust since 2017.
type: Occupation

occupation-webs-etf-trust-syntax-etf-trust-ceo-and-trustee-role
has occupation: CEO and Trustee
role name: CEO and Trustee at WEBS ETF Trust (Syntax ETF Trust)
start date: 2017
type: Role

Bond Street Marketplace
type: Organization

org-bond-street-marketplace-affiliation
affiliation: Bond Street Marketplace
description: Angel investor and board member of the fintech company Bond Street Marketplace.
role name: Angel Investor / Board Member
type: OrganizationRole

Feinstein Institute (Northwell Health)
type: Organization

org-feinstein-institute-northwell-health-affiliation
affiliation: Feinstein Institute (Northwell Health)
description: Director of the Feinstein Institute, the research arm of Northwell Health.
role name: Director
type: OrganizationRole

FibroGen Inc.
type: Organization

org-fibrogen-inc-affiliation
affiliation: FibroGen Inc.
description: Co-founder and director of FibroGen since October 1993 — his longest confirmed board tenure.
role name: Co-Founder and Director
start date: 1993-10
type: OrganizationRole

GeneNews / StageZero Life Sciences
type: Organization

org-genenews-stagezero-life-sciences-affiliation
affiliation: GeneNews / StageZero Life Sciences
description: Board Chair and director of GeneNews, later StageZero Life Sciences, since 1998.
role name: Board Chair / Director
start date: 1998
type: OrganizationRole

Intra-Cellular Therapies Inc.
type: Organization

org-intra-cellular-therapies-inc-affiliation
affiliation: Intra-Cellular Therapies Inc.
description: Director of Intra-Cellular Therapies from January 2014, serving on the Audit Committee.
end date: 2025
role name: Director, Audit Committee
start date: 2014-01
type: OrganizationRole

New York Genome Center
type: Organization

org-new-york-genome-center-affiliation
affiliation: New York Genome Center
description: Director of the New York Genome Center, his primary current nonprofit board.
role name: Board Member
type: OrganizationRole

Nuredis Inc.
type: Organization

org-nuredis-inc-affiliation
affiliation: Nuredis Inc.
description: Director of Nuredis Inc.
role name: Director
type: OrganizationRole

Rory Riggs
type: Organization

SUGEN Inc.
type: Organization

org-sugen-inc-affiliation
affiliation: SUGEN Inc.
description: Co-founder and board member of SUGEN.
role name: Co-Founder and Board Member
type: OrganizationRole

Syntax Data (Syntax LLC / Locus Analytics)
type: Organization

Rory Riggs
additional name: Balfour
affiliation: org-bond-street-marketplace-affiliation
affiliation: org-feinstein-institute-northwell-health-affiliation
affiliation: org-fibrogen-inc-affiliation
affiliation: org-genenews-stagezero-life-sciences-affiliation
affiliation: org-intra-cellular-therapies-inc-affiliation
affiliation: org-new-york-genome-center-affiliation
affiliation: org-nuredis-inc-affiliation
affiliation: org-sugen-inc-affiliation
alternate name: Rory B. Riggs
alternate name: Rory Balfour Riggs
alumni of: Columbia University
alumni of: Middlebury College
description: Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics. Mr. Riggs is Executive Chairman of Syntax Data, which has built a foundational coordinate-based information infrastructure for finance and economic data based on his patented Locus Model and Functional Information System (FIS).
disambiguating description: Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics.
family name: Riggs
gender: male
given name: Rory
has credential: BA
has credential: MBA
has occupation: Managing Member
has occupation: occupation-biomatrix-inc-president-cfo-and-director-role
has occupation: occupation-cibus-inc-chairman-of-the-board-role
has occupation: occupation-cibus-inc-chief-executive-officer-role
has occupation: Chair
has occupation: Chairman
has occupation: occupation-painewebber-inc-managing-director-mergers-acquisitions-role
has occupation: occupation-rfp-corporation-chief-executive-officer-role
has occupation: occupation-royalty-pharma-plc-chairman-and-founder-role
has occupation: General Partner / Co-Founder
has occupation: occupation-syntax-data-syntax-llc-locus-analytics-executive-chai-7ec1f0-role
has occupation: occupation-webs-etf-trust-syntax-etf-trust-ceo-and-trustee-role
job title: Executive Chairman / Founder
knows: BioMatrix Inc.
knows: Cibus Inc.
knows: Columbia University
knows: Feinstein Institute (Northwell Health)
knows: FibroGen Inc.
knows: Intra-Cellular Therapies Inc.
knows: Middlebury College
knows: New York Genome Center
knows: PaineWebber Inc.
knows: RF&P Corporation
knows: Royalty Pharma plc
knows: Scientia Ventures LLC
knows: SUGEN Inc.
knows: Syntax Data (Syntax LLC / Locus Analytics)
knows about: Functional classification systems
knows about: Index construction and portfolio classification
knows about: Mergers and acquisitions
knows about: Pharmaceutical royalty finance
knows about: Precision gene editing / agricultural biotechnology
knows language: English
subject of: Cibus Appoints Co-Founder Rory Riggs as Chief Executive Officer
subject of: Cibus Closes Calyxt Deal
subject of: Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
subject of: Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer
subject of: Cibus Opens Gene Editing Facility for Trait Production
subject of: Margaret Crotty and Rory Riggs Health Care Leadership Award, 2024
subject of: Regarding Cloe
subject of: Royalty Pharma Co-Founder Writes Open Letter to Board of Elan Ahead of EGM
subject of: Syntax LLC Announces Launch of Stratified LargeCap ESG Index
works for: Syntax Data (Syntax LLC / Locus Analytics)
type: Person

BioMatrix Inc.
description: President, CFO, and Director, 1996–2000; oversaw the launch of Synvisc.
type: Person

Cibus Inc.
description: Co-founder; CEO 2021–2026, then Chairman of the Board.
type: Person

Columbia University
description: Graduate alma mater (MBA).
type: Person

Feinstein Institute (Northwell Health)
description: Current director of the research arm of Northwell Health.
type: Person

FibroGen Inc.
description: Co-founder and director since October 1993.
type: Person

Intra-Cellular Therapies Inc.
description: Director, 2014–2025.
type: Person

Middlebury College
description: Undergraduate alma mater (BA).
type: Person

New York Genome Center
description: Current director.
type: Person

PaineWebber Inc.
description: Managing Director, Mergers & Acquisitions, 1981–1990.
type: Person

RF&P Corporation
description: CEO, 1991–1995, a Virginia State Retirement System–owned real estate investment company.
type: Person

Royalty Pharma plc
description: Co-founder and Chairman (2003–2024); built the pharmaceutical royalty asset class.
type: Person

Scientia Ventures LLC
description: General Partner and co-founder.
type: Person

SUGEN Inc.
description: Co-founder and board member.
type: Person

Syntax Data (Syntax LLC / Locus Analytics)
description: Founder and Executive Chairman; built the Locus Model, Functional Information System, and Syntax Stratified Indices.
type: Person

Rory Riggs
description: The personal site of Rory Riggs — inventor of the Locus Model and Functional Coordinates, founder of Systems Economics, and Executive Chairman of Syntax Data. Documents his work across financial classification (FIS, Syntax Stratified Indices), agricultural biotechnology (Cibus, Rapid Trait Development System), and pharmaceutical royalties (Royalty Pharma).
language: en
publisher: Rory Riggs
type: WebSite

Home
item: https://theroryriggs.com
position: 1
type: ListItem

Applications - Rory Riggs
item: https://theroryriggs.com/applications
position: 2
type: ListItem

Applications - Rory Riggs
item list element: collection-list-item-1
item list element: collection-list-item-10
item list element: collection-list-item-2
item list element: collection-list-item-3
item list element: collection-list-item-4
item list element: collection-list-item-5
item list element: collection-list-item-6
item list element: collection-list-item-7
item list element: collection-list-item-8
item list element: collection-list-item-9
number of items: 10
type: ItemList

collection-list-item-1
item: Commentary: Systems Economics — A New Prescription for Risk Management
position: 1
type: ListItem

collection-list-item-10
item: Proposed Merger Shows That When it Comes to Gene Editing, You Ain’t Seen Nothing Yet
position: 10
type: ListItem

collection-list-item-2
item: Gene Editing to Lead a New Agricultural Revolution
position: 2
type: ListItem

collection-list-item-3
item: Cibus Appoints Co-Founder Rory Riggs as Chief Executive Officer
position: 3
type: ListItem

collection-list-item-4
item: Syntax LLC Announces Launch of Stratified LargeCap ESG Index
position: 4
type: ListItem

collection-list-item-5
item: Cibus Opens Gene Editing Facility for Trait Production
position: 5
type: ListItem

collection-list-item-6
item: Cibus Closes Calyxt Deal
position: 6
type: ListItem

collection-list-item-7
item: Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
position: 7
type: ListItem

collection-list-item-8
item: Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer
position: 8
type: ListItem

collection-list-item-9
item: Royalty Pharma Co-Founder Writes Open Letter to Board of Elan Ahead of EGM
position: 9
type: ListItem

Applications - Rory Riggs
about: Rory Riggs
breadcrumb: breadcrumb
encoding: webpage-encoding-jsonld
encoding: webpage-encoding-n3
encoding: webpage-encoding-nq
encoding: webpage-encoding-nt
encoding: webpage-encoding-rdf
encoding: webpage-encoding-rj
encoding: webpage-encoding-trig
encoding: webpage-encoding-trix
encoding: webpage-encoding-ttl
language: en
is part of: Rory Riggs
main entity: Applications - Rory Riggs
publisher: Rory Riggs
type: CollectionPage

webpage-encoding-jsonld
encoding format: application/ld+json
type: MediaObject

webpage-encoding-n3
encoding format: text/n3
type: MediaObject

webpage-encoding-nq
encoding format: application/n-quads
type: MediaObject

webpage-encoding-nt
encoding format: application/n-triples
type: MediaObject

webpage-encoding-rdf
encoding format: application/rdf+xml
type: MediaObject

webpage-encoding-rj
encoding format: application/rdf+json
type: MediaObject

webpage-encoding-trig
encoding format: application/trig
type: MediaObject

webpage-encoding-trix
encoding format: application/xml
type: MediaObject

webpage-encoding-ttl
encoding format: text/turtle
type: MediaObject